ReviR Therapeutics

United States
Brisbane, California, United States, 94005

Company profile

ReviR Therapeutics company profile

ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs. Its RNA therapeutics treat cancer, rare genetic disorders, and infectious diseases. It also develops an AI-based and computation-empowered platform to discover RNA-targeting therapeutics.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2021-01-01, Year

Headquarters

Postal code
94005
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
4
Total equity funding
$50M
Last funding
Grant / $4.6M / 2025-01-30
Last equity funding
Series A / $30M
Investors
10
Lead investors
5
Founders
2
Articles
20

Founders and investors

Founders

Peng YueYang Li

Lead investors

5Y CapitalCalifornia Institute for Regenerative MedicineCDH InvestmentsCMT Research FoundationLapam Capital

Investors

5Y CapitalCDH InvestmentsShunwei CapitalSky9 CapitalXtalPi